• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Clinical observation of flumatinib combined with induction chemotherapy and sequential allogeneic hematopoietic stem cell transplantation in the treatment of 6 patients with newly diagnosed Ph(+) acute lymphocytic leukemia].

作者信息

Lian X Y, Dai H P, Cui Q Y, Tang X W

机构信息

The First Affiliated Hospital of Soochow University, Suzhou 215006, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):169-172. doi: 10.3760/cma.j.issn.0253-2727.2023.02.017.

DOI:10.3760/cma.j.issn.0253-2727.2023.02.017
PMID:36948876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10033262/
Abstract
摘要

相似文献

1
[Clinical observation of flumatinib combined with induction chemotherapy and sequential allogeneic hematopoietic stem cell transplantation in the treatment of 6 patients with newly diagnosed Ph(+) acute lymphocytic leukemia].氟马替尼联合诱导化疗及序贯异基因造血干细胞移植治疗6例初诊Ph(+)急性淋巴细胞白血病的临床观察
Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):169-172. doi: 10.3760/cma.j.issn.0253-2727.2023.02.017.
2
[Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].伊马替尼联合异基因造血干细胞移植改善了成人费城染色体阳性急性淋巴细胞白血病的治疗结果
Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):114-9. doi: 10.3760/cma.j.issn.0253-2727.2014.02.012.
3
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.异基因造血干细胞移植后微小残留病的清除及高危成人急性淋巴细胞白血病临床结局的预测
Haematologica. 2007 May;92(5):612-8. doi: 10.3324/haematol.10965.
4
[Acute lymphoblastic leukemia and chronic lymphocytic leukemia in adults].[成人急性淋巴细胞白血病和慢性淋巴细胞白血病]
Rinsho Ketsueki. 2012 Feb;53(2):164-75.
5
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.移植前伊马替尼为基础的治疗可改善 BCR-ABL 阳性急性淋巴细胞白血病患者异基因造血干细胞移植的疗效。
Leukemia. 2011 Jan;25(1):41-7. doi: 10.1038/leu.2010.228. Epub 2010 Oct 14.
6
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.成人Ph+急性淋巴细胞白血病采用伊马替尼、化疗和移植的序贯治疗方法：GIMEMA LAL 0904研究的最终结果
Haematologica. 2016 Dec;101(12):1544-1552. doi: 10.3324/haematol.2016.144535. Epub 2016 Aug 11.
7
Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation.伊马替尼联合化疗成功治疗异基因骨髓移植后复发的费城染色体阳性急性淋巴细胞白血病。
Rinsho Ketsueki. 2009 Nov;50(11):1612-5.
8
Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: major challenges in current practice.伊马替尼联合化疗治疗费城染色体阳性急性淋巴细胞白血病：当前实践中的主要挑战
Leuk Lymphoma. 2006 Sep;47(9):1747-53. doi: 10.1080/10428190600634085.
9
Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.达沙替尼诱导费城染色体阳性急性淋巴细胞白血病对既往含伊马替尼方案耐药患者异基因造血干细胞移植后完全分子缓解：1 例病例报告并讨论
Med Oncol. 2010 Dec;27(4):1123-6. doi: 10.1007/s12032-009-9347-0. Epub 2009 Nov 3.
10
Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is not necessary, at least in induction.费城染色体阳性急性淋巴细胞白血病的治疗应该强化吗？强化治疗并非必要，至少在诱导期是这样。
Clin Adv Hematol Oncol. 2016 Nov;14(11):892-896.

引用本文的文献

1
[Advances in basic and clinical research of flumatinib].氟马替尼的基础与临床研究进展
Zhonghua Xue Ye Xue Za Zhi. 2024 Jun 14;45(6):621-624. doi: 10.3760/cma.j.cn121090-20231211-00304.
2
Overcoming flumatinib resistance in chronic myeloid leukaemia: Insights into cellular mechanisms and ivermectin's therapeutic potential.克服慢性髓性白血病中的 flumatinib 耐药性：对细胞机制和伊维菌素治疗潜力的深入了解。
J Cell Mol Med. 2024 Jul;28(14):e18539. doi: 10.1111/jcmm.18539.
3
Clinical efficacy and safety of flumatinib versus dasatinib combined with multi-drug chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.氟马替尼与达沙替尼联合多药化疗治疗成人费城染色体阳性急性淋巴细胞白血病的临床疗效与安全性
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S71-S78. doi: 10.1016/j.htct.2023.12.005. Epub 2024 Feb 20.

本文引用的文献

1
Current Approaches to Philadelphia Chromosome-Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant.当前治疗费城染色体阳性 B 细胞谱系急性淋巴细胞白血病的方法：酪氨酸激酶抑制剂和干细胞移植的作用。
Curr Oncol Rep. 2021 Jun 14;23(8):95. doi: 10.1007/s11912-021-01086-y.
2
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study.氟马替尼与伊马替尼治疗新诊断的慢性期慢性髓性白血病：一项III期、随机、开放标签、多中心FESTnd研究。
Clin Cancer Res. 2021 Jan 1;27(1):70-77. doi: 10.1158/1078-0432.CCR-20-1600. Epub 2020 Sep 14.
3
Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.达沙替尼与伊马替尼治疗费城染色体阳性儿童急性淋巴细胞白血病的效果比较：一项随机临床试验。
JAMA Oncol. 2020 Mar 1;6(3):358-366. doi: 10.1001/jamaoncol.2019.5868.
4
Structure-based analysis and biological characterization of imatinib derivatives reveal insights towards the inhibition of wild-type BCR-ABL and its mutants.基于结构的分析和伊马替尼衍生物的生物学特性研究揭示了抑制野生型 BCR-ABL 及其突变体的新见解。
Bioorg Med Chem Lett. 2019 Dec 15;29(24):126758. doi: 10.1016/j.bmcl.2019.126758. Epub 2019 Oct 28.
5
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.一项关于化疗联合达沙替尼用于初治费城染色体阳性急性淋巴细胞白血病患者的2期研究的长期随访
Cancer. 2015 Dec 1;121(23):4158-64. doi: 10.1002/cncr.29646. Epub 2015 Aug 26.
6
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.移植前伊马替尼为基础的治疗可改善 BCR-ABL 阳性急性淋巴细胞白血病患者异基因造血干细胞移植的疗效。
Leukemia. 2011 Jan;25(1):41-7. doi: 10.1038/leu.2010.228. Epub 2010 Oct 14.
7
HH-GV-678, a novel selective inhibitor of Bcr-Abl, outperforms imatinib and effectively overrides imatinib resistance.HH-GV-678，一种新型的Bcr-Abl选择性抑制剂，其性能优于伊马替尼，并能有效克服伊马替尼耐药性。
Leukemia. 2010 Oct;24(10):1807-9. doi: 10.1038/leu.2010.169. Epub 2010 Aug 12.
8
How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.我如何治疗费城染色体阳性急性淋巴细胞白血病。
Blood. 2010 Nov 4;116(18):3409-17. doi: 10.1182/blood-2010-01-242750. Epub 2010 Jul 23.
9
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00.化疗相伊马替尼脉冲改善费城染色体阳性成人急性淋巴细胞白血病患者的长期预后：意大利北部白血病组方案 09/00。
J Clin Oncol. 2010 Aug 1;28(22):3644-52. doi: 10.1200/JCO.2010.28.1287. Epub 2010 Jul 6.
10
Philadelphia chromosome-positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病。
Hematol Oncol Clin North Am. 2009 Oct;23(5):1043-63, vi. doi: 10.1016/j.hoc.2009.07.007.